Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors

Transcription

1 Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors Agewall Stefan - Astra Zeneca : Platelet inhibition Bassand Jean-Pierre - Glaxo Smith Kline : fondaparinux - Lilly : prasugrel - Astra Zeneca : ticagrelor Bax Jeroen - Heart.org : Education - Astra Zeneca : Farma - Servier : Farma - Philips : Imaging - GE Healthcare : Imaging - Lantheus : Imaging - Boston Scientific : Pacing - Medtronic : Pacing - St Jude Medical : Pacing - Biotronik : Pacing - Impulse Dynamics : Pacing - Servier : Farma - Edwards Lifesciences : Heart Valves - GE Healthcare : Imaging - Lantheus : Imaging - Boston Scientific : Pacing - Medtronic : Pacing - St Jude Medical : Pacing

2 Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors Bax Jeroen - Biotronik : Pacing Boersma Eric - Medtronic : coronary artery disease Bueno Hector - Bayer Healthcare : Aspirin - Merck, Schering Plough : None - Daiichi Sankyo : Prasugrel - Eli Lilly : Prasugrel - Astra Zeneca : Ticagrelor Caso Pio - Consorzio formazione medica : lessons C - Receipt of royalties for intellectual property. - piccin nuova libraria spa : book Dudek Dariusz - Boehringer-Ingelheim : speaker fee, advisory boards, investigator. - Boston Scientific : speaker fee, advisory boards, investigator. - Eli Lilly : speaker fee, advisory boards, investigator. - Pfizer : speaker fee, advisory boards, investigator. - Sanofi Aventis : speaker fee, advisory boards, investigator. - Siemens Healthcare : speaker fee, advisory boards, investigator. - GlaxoSmithKline : speaker fee, advisory boards, investigator. - Bayer Healthcare : speaker fee, advisory boards, investigator. - Cook Medical : speaker fee, advisory boards, investigator. - Medicines Company : speaker fee, advisory boards, investigator. - Nycomed : speaker fee, advisory boards, investigator. - Bristol Myers Squibb : speaker fee, advisory boards, investigator. - MSD : speaker fee, advisory boards, investigator.

3 Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors Dudek Dariusz - Balton : speaker fee, advisory boards, investigator. - Cordis : speaker fee, advisory boards, investigator. - Biotronic : speaker fee, advisory boards, investigator. - Solvay : speaker fee, advisory boards, investigator. - BBraun : speaker fee, advisory boards, investigator. - EuroCor : speaker fee, advisory boards, investigator. - INvatec : speaker fee, advisory boards, investigator. - Medtor : speaker fee, advisory boards, investigator. - Promed : speaker fee, advisory boards, investigator. - Therumo : speaker fee, advisory boards, investigator. - Tyco : speaker fee, advisory boards, investigator. E - Research funding (personal). - Abbott : speaker fee, advisory boards, investigator. - Adamed : speaker fee, advisory boards, investigator. - Astra Zeneca : speaker fee, advisory boards, investigator. - Boehringer-Ingelheim : speaker fee, advisory boards, investigator. - Boston Scientific : speaker fee, advisory boards, investigator. - Eli Lilly : speaker fee, advisory boards, investigator. - Medtronic : speaker fee, advisory boards, investigator. - Pfizer : speaker fee, advisory boards, investigator. - Biotronik : speaker fee, advisory boards, investigator. - Terumo Inc : speaker fee, advisory boards, investigator. - Sanofi Aventis : speaker fee, advisory boards, investigator. - Siemens Healthcare : speaker fee, advisory boards, investigator. - GlaxoSmithKline : speaker fee, advisory boards, investigator.

4 Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors Dudek Dariusz - Bayer Healthcare : speaker fee, advisory boards, investigator. - Cook Medical : speaker fee, advisory boards, investigator. - Nycomed : speaker fee, advisory boards, investigator. - MSD : speaker fee, advisory boards, investigator. - Balton : speaker fee, advisory boards, investigator. - Cordis : speaker fee, advisory boards, investigator. - Solvay : speaker fee, advisory boards, investigator. - BBraun : speaker fee, advisory boards, investigator. - EuroCor : speaker fee, advisory boards, investigator. - INvatec : speaker fee, advisory boards, investigator. - Promed : speaker fee, advisory boards, investigator. - Tyco : speaker fee, advisory boards, investigator. - Biomatrix : speaker fee, advisory boards, investigator. - Mediciine Company : speaker fee, advisory boards, investigator. Gielen Stephan - Genzyme : Lecture on genetic cardiac diseases incl. M. Fabry, 1000 honorarium - Astra zeneca, boheringer, menarini : Product-independent cardiology case workshop twice a year, honorarium per event Hamm Christian - Merck : drugs - Pfizer : drugs - Sanofi-Aventis : drugs - The Medicines Company : drugs - Menarini : drugs - Daiichi-Sankyo : drugs - Berlin Chemie AG : drugs

5 Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors Hamm Christian - Heart.org : drugs - Boehringer Ingelheim - Ingelheim; Daiichi-Sankyo/Eli Lilly; Nycomed Pharma : drugs - Takeda Pharmaceuticals : drugs - Glaxo Smith Kline : drugs - Astra Zeneca, Bayer AG, Boehringer-Ingelheim, Daiichi-Sankyo, MSD, Novartis, Pfizer, Sanofi-Aventis, Servier : drugs - BRAHMS GmbH : markers - Siemens Healthcare : MRI - Boston Scientific : PCI - Cordis and Medtronic : PCI Huber Kurt - Pfizer - speakers fees : atorvastatin - The Medicines Company - speakers fees : bivalirudin; cangrelor - BRAHMS GmbH - speakers fees : copeptin assay - Boehringer Ingelheim - speakres fees; advisory board fees (dabigatran) : dabigatran - Boston Scientific - speakres fees : none - Biotronik - speakers fees : none - Eli Lilly Lilly/Daiichi Sankyo - speakers fees; advisory board fees (prasugrel) : prasugrel; abciximab - Bayer - speaker fees; advisory board fees (rivaroxaban) : rivaroxaban - Astra Zeneca - speakers fees; advisory board fees (ticagrelor) : ticagrelor; rosuvastatin Ohman E Magnus - Liposcience : Diagnostic tests - WebMD : Online health information provider - Astra Zeneca : Pharmaceuticals - Boehringer-Ingelheim : Pharmaceuticals - The Medicines Company : Pharmaceuticals

6 Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors Ohman E Magnus - Sanofi Aventis : Pharmaceuticals - Bristol Myers Squibb : Pharmaceuticals - Merck Sharp & Dohme : Pharmaceuticals - Gilead Sciences : Pharmaceuticals - Pozen, Inc. : Pharmaceuticals - Daiichi Sankyo : Pharmaceuticals - Eli Lilly : Pharmaceuticals - Maquet : Medical technology/products - Daiichi Sankyo : Pharmaceuticals - Eli Lilly : Pharmaceuticals Petrie Mark - Roche : diabetes - GSK : diabetes - Astellas : diabetes - Servier : heart failure Sonntag Frank - Servier : CAD - Sanofii-Aventis : CAD - Bayer Healthcare : CAD - Merck Sharp & Dome : CAD - Boehringer Ingelheim - : CAD - Astra Zeneca : CAD,Plateletaggregationinhibitor Sousa Uva Miguel - Medtronic : TAVI

7 Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors Sousa Uva Miguel - Lilly : Antiplatelet agent Storey Robert Frederick - The Medicines Company : Cangrelor - Sanofi Aventis : Clopidogrel - Bristol Myers Squibb : Clopidogrel - Novartis : Elinogrel - GlaxoSmithKline : Fondaparinux - Eli Lilly Lilly/Daiichi Sankyo - speakers fees; advisory board fees (prasugrel) : Prasugrel - Astra Zeneca : Ticagrelor - Merck : Vorapaxar - Astra Zeneca : Ticagrelor - Accumetrics : VerifyNow - Daiichi Sankyo : Prasugrel - Eli Lilly : Prasugrel - Astra Zeneca : Ticagrelor - Merck : Vorapaxar Wijns William - Boston Scientific : device - Edwards Lifesciences : device - Terumo Inc : device - Cordis : device - Orbus Neich : device - Astra Zeneca : drug

8 Guidelines on ACS-NSTE (TF21) - TF Members and Additional Contributors Wijns William - Eli Lilly : drug - GlaxoSmithKline : drug - Bristol Myers Squibb : drug - Cardio3 Biosciences : cell therapy - Boston Scientific : device - Medtronic : device - St Jude Medical : device - Abbott Laboratories : device - Biotronic : device - Therabel : drug - Ablynx : nano antibodies Zahger Doron - Sanofi Aventis : Dronedarone - Pfizer : lipitor - Eli Lilly : prasugrel - Astra zeneca, boheringer, menarini : Ticagrelor

9 Guidelines on ACS-NSTE (TF21) - Document Reviewers Achenbach Stephan - Siemens Healthcare : CT - Servier : Imaging - Guerbet : Imaging - Siemens Healthcare : Imaging - Bayer Healthcare : Imaging Badimon Lina - Astra Zeneca : cardiovascular - Menarini : cardiovascular - Esteve : Cardiovascular Bertrand Michel - Lilly : Anticoagulants - Servier International : Antihypertensive drugs. Antiischemic drugs Botker Hans Erik - Astra Zeneca - speaker fee : Hyperlipidema, angina pectoris Collet Jean-Philippe - Bristol Myers Squibb : apixaban - Nycomed : aspirin - Sanofi Aventis : clopidogrel - Roche Diagnostics : hypersensitive troponin - Astra Zeneca : prasugrel - Eli Lilly : prasugrel - Sanofi-Aventis : clopidogrel - Cordis and Medtronic : platelet function testing Crea Filippo - Pfizer - speakers fees : Atorvastatin

10 Guidelines on ACS-NSTE (TF21) - Document Reviewers Crea Filippo - Boehringer Ingelheim-Advisory Board : Dabigatran - GSK : Darapladip - Sanofi Aventis - speaker fee : Prasugrel - Astra Zeneca - speaker fee : Rosuvastatin - Chiesi - speaker fees : Rosuvastatin - Pfizer : Atorvastatin - Sanofi Aventis : Prasugrel - Chiesi - speaker fees : Rosuvastatin Danchin Nicolas - Servier : antianginal agents - The Medicines Company : Antithrombotic agents - BMS/Pfizer : Antithrombotic agents - Boehringer Ingelheim : Antithrombotic agents - Daiichi Sankyo, Eli-Lilly : Antithrombotic agents - Sanofi-Aventis : antithrombotic agents, antiarrhythmic agents - Astra-Zeneca : Antithrombotic agents, statins - Novo-Nordisk : Diabetes - Pierre Fabre : Omega 3 - Merck : Myocardial infarction - Sanofi-Aventis : Myocardial infarction - The Medicines Company : Myocardial infarction - GSK : Myocardial infarction - Astra-Zeneca : Myocardial infarction - Daiichi-Sankyo Eli Lilly : Myocardial infarction

11 Guidelines on ACS-NSTE (TF21) - Document Reviewers Falk Erling Goudevenos John A No No Gulba Dietrich Cl - The Medicines Company : Bivalirudin - Boehringer-Ingelheim : Dabigatran, rt-pa, TNK-tPA - Sanofi Aventis : Enoxaparin - Daiichi Sankyo : Prasugrel - Eli Lilly : Prasugrel, abciximab - Bayer Healthcare : Rivaroxaban - Astra Zeneca : Ticagrelor Hambrecht Rainer - Berlin Chemie : ranolazine Herrmann Joerg No - pohl boskamp : nitrates Kastrati Adnan - Abbott - lecture fees : DES Kjeldsen Keld Per No - Astra Zeneca : Antiplatelet - Lilly : Antiplatelet - Biosensors : DES - Cordis : DES - Biotronic : DES Kristensen Steen Dalby - Daiichi Sankyo : Antithrombotics - Eli Lilly : Antithrombotics

12 Guidelines on ACS-NSTE (TF21) - Document Reviewers Kristensen Steen Dalby - Merck : Antithrombotics - The Medicines Company : Antithrombotics - AstraZeneca : Antithrombotics Lancellotti Patrizio -,astra zeneca, boheringer, menarini : pradaxa, belsar, crestor - Actelion : tracleer Mehilli Julinda - Daiichi Sankyo - speaker fee : Antithrombotic drugs - Abbott - lecture fees : Stents - Abbott : Unrestricted grant for clinical studies - Terumo : Unrestricted grant for clinical studies Merkely Bela - Abbott, Biotronik, Boston Sci, Medtronic, Sanofi-Aventis, Servier, St. Jude : CRT implantation, ICD programing, education program, dronaderone, ivabradine Montalescot Gilles - Abbott, Johnson & Johnson, Medtronic, : Xience V stent, education program - Astra Zeneca - consulting or lecture fees : xy - Bayer - consulting or lecture fees : xy - Boehringer Ingelheim - consulting or lecture fees : xy - Cardiovascular Research Foundation - consulting or lecture fees : xy - Cleveland Clinic Research Foundation - consulting or lecture fees : xy - Daiichi Sankyo - consulting or lecture fees : xy - Duke Institute - consulting or lecture fees : xy - Eli Lilly - consulting or lecture fees : xy

13 Guidelines on ACS-NSTE (TF21) - Document Reviewers Montalescot Gilles - Europa - consulting or lecture fees : xy - Lead-Up - consulting or lecture fees : xy - GSK - consulting or lecture fees : xy - Institut de Cardiologie de Montreal - consulting or lecture fees : xy - Menarini - consulting or lecture fees : xy - Nanospheres - consulting or lecture fees : xy - Novartis - consulting or lecture fees : xy - Pfizer - consulting or lecture fees : xy - Portola - consulting or lecture fees : xy - Sanofi Aventis - consulting or lecture fees : xy - The Medicines Company - consulting or lecture fees : xy - TIMI study group - consulting or lecture fees : xy - Astra Zeneca : xy - BMS : xy - Boston Scientific : xy - Eli Lilly : xy - Medtronic : xy - Pfizer : xy - Servier : xy - Sanofi Aventis : xy - Abbott Vascular : xy - Cordis : xy - Fédération Française de Cardiologie : xy - Fondation de France : xy

14 Guidelines on ACS-NSTE (TF21) - Document Reviewers Montalescot Gilles - Guerbet Medical : xy Neumann Franz Josef - INSERM : xy - ITC Edison : xy - Société Française de Cardiologie : xy - Stago : xy - Boston Scientific : devices - Medtronic : devices - Cordis : devices - Biotronic : devices - Astra Zeneca : drugs - The Medicines Company : drugs - Lilly : drugs - Siemens Healthcare : equipment - Boston Scientific : devices - Cordis : devices - Metronic : devices - Lilly : drugs Neyses Ludwig - Servier - speaker fees; investigator fees : Ivabradine - Johnson & Johnson : Diagnostic use of metabolomics Perk Joep - Astra Zeneca - speaker fees : None specific

15 Guidelines on ACS-NSTE (TF21) - Document Reviewers Perk Joep - Astra Zeneca : None specific Pfisterer Matthias No Roffi Marco - Eli Lilly Lilly/Daiichi Sankyo - speakers fees; advisory board fees (prasugrel) : Antiplatelet therapy Romeo Francesco Ruda Mikhail Ya Swahn Eva Tavares Aguiar Carlos Manuel No No - Abbott : devices - Boston Scientific : devices - Cordis and Medtronic : devices - Biotronik : devices - Schering-Plough : Phase III study (TRACER) - Merck Sharp & Dohme - speaker fees : Niacin/Laropiprant - Menarini - speaker fees : Olmesartan - Servier - speaker fees; investigator fees : Perindopril/Indapamide, Ivabradine - Lilly - consultancy fees : Prasugrel - Bayer - speaker fees; advisory board fees (rivaroxaban) : Rivaroxaban, Nifedipine, Telmisartan, Aspirin - Astra Zeneca - speaker fees : Rosuvastatin - Boehringer Ingelheim - speaker fees : Telmisartan - Bial Portela - speaker fees : Valsartan/Amlodipine Valgimigli Marco - The Medicines Company : bivalirudin - Terumo : Interventional cardiology

16 Guidelines on ACS-NSTE (TF21) - Document Reviewers Valgimigli Marco - Abbott Laboratories : ngal Vrints Christian Joseph Marie - Accumetrics : Platlet Function Assay - Roche Pharma : PPAR alpha/gamma - Medtronic : stent - Abbott Vascular : stent - Cordis : stent - CID : stent - Astra Zeneca - consulting or lecture fees : ticagrelor - Chiesi Pharma : tirofiban - Iroko Cardio : Tirofiban - Abbott Laboratories : ngal - Bayer : pharma - Abbott : interventional cardiology - Medtronic : pacing Widimsky Petr - Servier : Antiischemic agents - Astra Zeneca : Antithrombotic agents - Bayer : Antithrombotic agents - Boehringer-Ingelheim : Antithrombotic agents - Daiichi Sankyo : Antithrombotic agents - Eli Lilly : Antithrombotic agents - The Medicines Company : Antithrombotic agents

17 Guidelines on ACS-NSTE (TF21) - Document Reviewers Widimsky Petr - Duke University : Antithrombotic agents - Abbott : Stents - Boston Scientific : Stents - Medtronic : Stents

18 ESC Committee for Practice Guidelines Auricchio Angelo Baumgartner Helmut Bax Jeroen - Biologics Delivery Systems, Cordis Corporation a Johnson & Johnson company : Biological Therapy - Philips : Cardiac Imaging - Merck : Drugs - Biotronik : Implantable Cardiac Electronic Device - EBR Systems : Implantable Cardiac Electronic Device - Impulse Dynamics : Implantable Cardiac Electronic Device - Medtronic : Implantable Cardiac Electronic Device - Sorin : Implantable Cardiac Electronic Device - St. Jude Medical : Implantable Cardiac Electronic Device - Abbott : Implantable Cardiac Electronic Device - Actelion : Bosentan for PAH treatment in congenital heart disease - AGA : Devices for catheter treatment of congenital heart defects - Edwards Lifesciences : transcatheter valve implantation - Heart.org : Education - Servier : Farma - Astra Zeneca : Farma - GE Healthcare : Imaging - Lantheus : Imaging - Philips : Imaging - St Jude Medical : Pacing

19 ESC Committee for Practice Guidelines Bax Jeroen Ceconi Claudio Deaton M Christi Fagard Robert Funck-Brentano Christian - Medtronic : Pacing - Impulse Dynamics : Pacing - Biotronik : Pacing - Boston Scientific : Pacing - Servier : Farma - Edwards Lifesciences : Heart Valves - Lantheus : Imaging - GE Healthcare : Imaging - Boston Scientific : Pacing - Medtronic : Pacing - St Jude Medical : Pacing - Biotronik : Pacing - Servier : Pharmaceutical - St Jude Ltd : Cath lab - speaker X 1 - Daiichi Sankyo : consultant for patient adherence Eli Lilly : consultant for patient adherence Novo Nordisk : medicines for diabetes - Servier : perindopril; support for organisation of scientific meeting - Pierre-Fabre : Cardiac Safety of non-cardiovasclar products

20 ESC Committee for Practice Guidelines Funck-Brentano Christian Hasdai David Hoes Arno Knuuti Juhani Kolh Philippe H - Servier : Cardiac safety of non-cardiovascular drugs under development or on the market. Design of phase I/II trials. - Johnson & Johnson : Cardiac safety of non-cardiovascular drugs under development or on the market. Design of phase I/II trials. - Sigma-Tau (Italy) : Cardiac Saftey of an antimalarial drug - Santhera (CH) : Cardiac Saftey of an antimalarial drug - MMV (CH) : Cardiac Saftey of an antimalarial drug - TROPHOS : DSMB for an investigational drug in Amyotrophic Lateral Sclerosis Cardiac safety - CEPHALON : DSMB in an oncology phase IIb trial - Jansen-Cilag : Proton-pump inhibitors and drug interactions, including Clopidogrel - Jansen-Cilag : Proton-pump inhibitors and drug interactions with Clopidogrel - Sanofi Aventis : Enoxaparin - Bayer Healthcare : unresctricted grant for diagnostic kits in suspected cardiovascualar disease - Abbott Laboratories : unresctricted grant for diagnostic kits in suspected cardiovascualar disease - Roche : unresctricted grant for diagnostic kits in suspected heart failure and acute coronary syndrome - Lantheus Inc : Imaging tracers - Bayer : Development of imaging agents - GE Healthcare : Development of imaging agents - Lantheus : Development of imaging agents - Novartis : Development of imaging agents - Roche : Drugs for brain diseases

21 ESC Committee for Practice Guidelines Kolh Philippe H McDonagh Theresa Poldermans Don - Merck Sharp & Dohme : Antiarrhythmic agents - Bristol Myers Squibb : Antiplatelet agents - Astra Zeneca : Antiplatelet agents - Regado Biosciences : Antithrombotic agents - Abbott - lecture fees : coronary stents - Merck Sharp & Dohme : Antistaphylococcic vaccine - Edwards Lifesciences : Cardiac valves - Medtronic : Cardiac valves - St Jude Medical : Cardiac valves - Siemens Healthcare : Imaging - Johnson & Johnson : Thoracoscopic devices - Vifor International : Ferrinject - Servier - speaker fee : Ivabridine - Biotronik - Clinical Trial : CRT - Maquette : Balloon pump device - Merck : drugs - Novartis : drugs - Baxter : drugs - Medtronic : Reveal device

22 ESC Committee for Practice Guidelines Popescu Bogdan Alexandru Reiner Zeljko Sechtem Udo Sirnes Per Anton - GE Healthcare : Imaging - Bayer Healthcare : anticoagulants - Abbott - lecture fees : antilipemics - Astra Zeneca : antilipemics - Merck Sharp & Dohme : antilipemics - Pfizer : antilipemics - Boehringer Ingelheim : Anticoagulation - Daiichi Sankyo : Antiplatelet therapy - Novartis : Drugs - General Electric : Imaging - Siemens Healthcare : Imaging - Novartis : Imaging devices - Johnson & Johnson : Stents - Bayer : clinical studies atrial fibrillation investigator fee - Johnson & Johnson : inestigator fee, ckinical study, atrial fibrillation - MSD : investgator fee clinical studies hyperlipidemia, SCAD - Glaxo Smith Kline : investigator fee, clinical study, SCAD - Servier : investigator fee, clinical study, coronary artery disease - Jansen-Cilag : investigator fee, clinical study, diabetes CVD - Boehringer Ingelheim : investigator fee, clinicla study, AF

23 ESC Committee for Practice Guidelines Torbicki Adam Vahanian Alec Windecker Stephan - Boehringer-Ingelheim : anticoagulation - Sanofi Aventis : anticoagulation - Pfizer : anticoagulation, pulmonary hypertension - Lilly : pulmonary hypertension - Actelion : pulmonary hypertension - Bayer Healthcare : pulmonary hypertension, anticoagulation - Boehringer Ingelheim : Valve prostheses - Siemens Healthcare : Valve prostheses - Valtech : Valve prostheses - Edwards Lifesciences : Valve prostheses - Abbott : Valve prostheses - Medtronic - Advisory Board : Valve prostheses - Astra Zeneca : Antiplatelet drug - Eli Lilly : Antiplatelet drug - Abbott : Stent - Biosensors : Stent - Biotronik : Stent - Boston Scientific : Stent - Cordis : Stent - Medtronic : Stent - Medtronic : Stent

24 ESC Committee for Practice Guidelines Abbott : Stent - Biosensors : Stent - Cordis : Stent This table represents the relevant relationships of the above experts and other entities that were reported to us at the time of publication of the guidelines.